| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |